Probi AB (publ)
SSE:PROB.ST
203 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Probi AB (publ) |
Symbool | PROB.ST |
Munteenheid | SEK |
Prijs | 203 |
Beurswaarde | 2,313,002,300 |
Dividendpercentage | 0.63% |
52-weken bereik | 165 - 216 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Anita Johansen |
Website | https://www.probi.com |
An error occurred while fetching data.
Over Probi AB (publ)
Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)